Schroder Investment Management Group Maravai Lifesciences Holdings, Inc. Transaction History

Schroder Investment Management Group

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$12.5 - $24.78 $1.02 Million - $2.02 Million	-81,567 Reduced 65.1%	43,729 $625,000
Q3 2022 Nov 10, 2022	SELL	$20.6 - $30.37 $864,005 - $1.27 Million	-41,942 Reduced 25.08%	125,296 $3.2 Million
Q2 2022 Aug 11, 2022	SELL	$26.05 - $37.48 $260,369 - $374,612	-9,995 Reduced 5.64%	167,238 $4.65 Million
Q1 2022 May 16, 2022	BUY	$24.46 - $40.92 $2.68 Million - $4.49 Million	109,669 Added 162.32%	177,233 $6.32 Million
Q4 2021 Feb 14, 2022	BUY	$35.0 - $45.94 $1.76 Million - $2.31 Million	50,221 Added 289.58%	67,564 $2.83 Million
Q3 2021 Nov 12, 2021	BUY	$36.8 - $60.62 $638,222 - $1.05 Million	17,343 New	17,343 $851,000

227

140M

237K

19.4K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $650M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

Stay updated on Schroder Investment Management Group with notifications on news.